Stem cells reside in specialized niches that allow them to self-renew, proliferate, differentiate and migrate according to the organism’s requirements. Our group studies the mechanisms by which the stem cell niche fulfils these complex functions and how its deregulation contributes to disease.
Our recent work has described a tight regulation of the bone marrow stem cell niche by circadian oscillations of sympathetic activity. Light onset induces noradrenaline release in the bone marrow, leading to rapid downregulation of CXCL12/SDF-1, the only chemokine known to direct haematopoietic stem cell (HSC) migration. Our recent studies indicate that the stromal cells targeted by the sympathetic nervous system that regulate HSC traffic are peri-vascular nestin+ cells. These cells are true niche cells: they colocalize with HSC, express high levels of core HSC maintenance genes, selectively downregulate these genes during HSC mobilisation and their deletion triggers significant alterations in bone marrow HSC homing and content. Interestingly, peri-vascular nestin+ cells are also functional mesenchymal stem cells (MSC): they account for all mesenchymal activity, show clonal multilineage differentiation, display robust self-renewal in serial transplantations and contribute to osteochondral lineages in vivo. These findings suggest that the bone marrow stem cell niche is composed of a unique pairing of MSC and HSC, tightly regulated by local input from the microenvironment and by long-distance cues from hormones and the autonomic nervous system.
We are currently investigating novel physiological mechanisms that regulate the stem cell niche and contribute to pathogenesis, with the ultimate goal of devising more efficient therapeutic approaches targeting the stem cell niche.
Figure 1:
Peri-vascular nestin+ mesenchymal stem cells are innervated by sympathetic fibers in the bone marrow. Projection stack (~100 µm) of fluorescent images showing the distribution of Nestin-GFP+ cells (green), CD31/PECAM+ vascular endothelial cells (blue) and tyrosine hydroxylase+ sympathetic nerve fibers (red) after whole mount staining of the skull bone marrow.
Figure 2:
A bone marrow stem cell niche made for two. Projection stack (~15 µm) of fluorescent images showing a CD150+ (red) CD48-, CD3e-, Ter119-, Gr1-, B220- and CD11b- (antigens labeled in blue) hematopoietic stem cell adjacent to a nestin-GFP+ mesenchymal stem cell (green) in the bone marrow (from Nature 466: 829-34). Grid, 50 µm.
Simón Méndez-Ferrer se licenció en Ciencias Biológicas por la Universidad de Sevilla en 1998 y se doctoró en la misma universidad en 2004. En su trabajo de tesis doctoral, llevada a cabo en el Departamento de Fisiología Médica bajo la dirección de José López-Barneo y Juan José Toledo-Aral, caracterizó propiedades del cuerpo carotideo de interés potencial para planear estrategias terapeúticas en procesos neurodegenerativos basadas en la liberación biológica de catecolaminas y factores neurotróficos. Su trabajo posdoctoral en el laboratorio de Paul S. Frenette en Mount Sinai School of Medicine (Nueva York, 2006-09) demostró que el tráfico de células troncales hemopoyéticas entre la médula ósea y la sangre está regulado por ritmos circadianos y determinó los mecanismos subyacentes. Su trabajo posterior como Assistant Professor en Mount Sinai School of Medicine (2009-10) identificó células troncales mesenquimales autorrenovables utilizando la expresión de la nestina y determinó su papel clave en el nicho hemopoyético. Simón se incorporó al CNIC a finales de 2010 y su trabajo está financiado a través del Programa Ramón y Cajal.